JP2009523124A - 置換されたイミダゾリン誘導体 - Google Patents

置換されたイミダゾリン誘導体 Download PDF

Info

Publication number
JP2009523124A
JP2009523124A JP2008546224A JP2008546224A JP2009523124A JP 2009523124 A JP2009523124 A JP 2009523124A JP 2008546224 A JP2008546224 A JP 2008546224A JP 2008546224 A JP2008546224 A JP 2008546224A JP 2009523124 A JP2009523124 A JP 2009523124A
Authority
JP
Japan
Prior art keywords
dimethylamino
phenyl
dihydro
imidazole
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2008546224A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009523124A5 (enExample
Inventor
マーラ・ベアトリクス
オーバーベルシュ・シュテファン
ズンダーマン・ベルント
エングルベルガー・ヴェルナー
ヘンニース・ハーゲン−ハインリヒ
グラウバウム・ハインツ
Original Assignee
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング filed Critical グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング
Publication of JP2009523124A publication Critical patent/JP2009523124A/ja
Publication of JP2009523124A5 publication Critical patent/JP2009523124A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2008546224A 2005-12-22 2006-12-19 置換されたイミダゾリン誘導体 Ceased JP2009523124A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005061430A DE102005061430A1 (de) 2005-12-22 2005-12-22 Substituierte Imidazolin-Derivate
PCT/EP2006/012221 WO2007079927A1 (de) 2005-12-22 2006-12-19 Substituierte imidazolin-derivate

Publications (2)

Publication Number Publication Date
JP2009523124A true JP2009523124A (ja) 2009-06-18
JP2009523124A5 JP2009523124A5 (enExample) 2012-12-13

Family

ID=37946192

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008546224A Ceased JP2009523124A (ja) 2005-12-22 2006-12-19 置換されたイミダゾリン誘導体

Country Status (17)

Country Link
US (1) US7728028B2 (enExample)
EP (1) EP1963278B1 (enExample)
JP (1) JP2009523124A (enExample)
CN (1) CN101384557A (enExample)
AT (1) ATE449075T1 (enExample)
AU (1) AU2006334743B2 (enExample)
CA (1) CA2633918A1 (enExample)
CY (1) CY1110465T1 (enExample)
DE (2) DE102005061430A1 (enExample)
DK (1) DK1963278T3 (enExample)
ES (1) ES2336833T3 (enExample)
IL (1) IL192268A0 (enExample)
PL (1) PL1963278T3 (enExample)
PT (1) PT1963278E (enExample)
RU (1) RU2427571C2 (enExample)
SI (1) SI1963278T1 (enExample)
WO (1) WO2007079927A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2257526T3 (pl) 2008-03-27 2012-05-31 Gruenenthal Gmbh Pochodne spiro (5.5) undekanu
US8357705B2 (en) 2008-03-27 2013-01-22 Gruenenthal Gmbh Substituted cyclohexyldiamines
ES2694103T3 (es) 2008-03-27 2018-12-18 Grünenthal GmbH Derivados de 4-aminociclohexano sustituidos
CL2009000731A1 (es) 2008-03-27 2009-05-15 Gruenenthal Gmbh Compuestos derivados de ciclohexano espirociclicos sustituidos, composicion farmaceutica que contiene a dicho compuesto y su uso como moduladores del receptor de opioides µ y el receptor orl-1 para tratar el dolor, ansiedad, depresion, epilepsia, alzheimer, abuso de alcohol, hipertension, anorexia, obesidad y diarrea.
JP5599774B2 (ja) 2008-03-27 2014-10-01 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング ヒドロキシメチルシクロヘキシルアミン類
HUE026184T2 (en) 2008-03-27 2016-05-30 Gruenenthal Gmbh (Hetero-) aryl-cyclohexane derivatives

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513556A (ja) * 1997-08-28 2001-09-04 イーライ・リリー・アンド・カンパニー ニューロパシー痛の治療方法
JP2001513532A (ja) * 1997-08-28 2001-09-04 イーライ・リリー・アンド・カンパニー 痛みを処置するための方法
JP2003519210A (ja) * 2000-01-05 2003-06-17 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 置換アミノメチル−フェニル−シクロヘキサン誘導体
WO2004066996A1 (en) * 2003-01-17 2004-08-12 Michigan State University NF-kB INHIBITORS AND USES THEREOF

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7183276B2 (en) * 2002-02-28 2007-02-27 Takeda Pharmaceutical Company Limited Azole compounds
US6878735B2 (en) * 2002-05-31 2005-04-12 Board Of Trustees Of Michigan State University Multi-substituted imidazolines and method of use thereof
DE102005061429A1 (de) * 2005-12-22 2007-06-28 Grünenthal GmbH Substituierte Oxazol-Derivate

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513556A (ja) * 1997-08-28 2001-09-04 イーライ・リリー・アンド・カンパニー ニューロパシー痛の治療方法
JP2001513532A (ja) * 1997-08-28 2001-09-04 イーライ・リリー・アンド・カンパニー 痛みを処置するための方法
JP2003519210A (ja) * 2000-01-05 2003-06-17 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 置換アミノメチル−フェニル−シクロヘキサン誘導体
WO2004066996A1 (en) * 2003-01-17 2004-08-12 Michigan State University NF-kB INHIBITORS AND USES THEREOF

Also Published As

Publication number Publication date
PT1963278E (pt) 2009-12-16
SI1963278T1 (sl) 2010-03-31
DE502006005426D1 (de) 2009-12-31
EP1963278B1 (de) 2009-11-18
US20090048323A1 (en) 2009-02-19
ATE449075T1 (de) 2009-12-15
AU2006334743A1 (en) 2007-07-19
RU2427571C2 (ru) 2011-08-27
CN101384557A (zh) 2009-03-11
US7728028B2 (en) 2010-06-01
CA2633918A1 (en) 2007-07-19
WO2007079927A1 (de) 2007-07-19
CY1110465T1 (el) 2015-04-29
AU2006334743B2 (en) 2011-07-07
HK1122019A1 (zh) 2009-05-08
EP1963278A1 (de) 2008-09-03
IL192268A0 (en) 2008-12-29
DE102005061430A1 (de) 2007-07-05
DK1963278T3 (da) 2010-03-29
PL1963278T3 (pl) 2010-04-30
RU2008129377A (ru) 2010-03-27
ES2336833T3 (es) 2010-04-16

Similar Documents

Publication Publication Date Title
JP4791374B2 (ja) スピロ環状シクロヘキサン誘導体
US8124788B2 (en) Spirocyclic cyclohexane compounds with analgesic activity
US5352788A (en) N-substituted heterocyclic derivatives
RU2525236C2 (ru) Замещенные производные 4-аминоциклогексана
JP5599774B2 (ja) ヒドロキシメチルシクロヘキシルアミン類
US7589113B2 (en) Substituted oxadiazole compounds and their use as opioid receptor ligands
JP4982357B2 (ja) ヘテロアリール−置換されたシクロヘキシル−1,4−ジアミン誘導体
IL103116A (en) History of N-transformed heterocyclics, pharmaceutical preparations containing certain compounds and their preparation
US7728028B2 (en) Substituted imidazoline compounds
PT1751093E (pt) Derivados de ácido ciclo-hexilacético substituídos
AU691057B2 (en) 3-alkoxybenzylpiperidine derivatives as melatonergic agents
EA015974B1 (ru) Производные пирролизина, индолизина и хинолизина, их получение и их применение в терапии
JP4874237B2 (ja) 置換されたシクロヘキシルカルボン酸誘導体
JP6216385B2 (ja) 3,4−二置換オキサゾリジノン誘導体及びカルシウム活性化カリウムチャネルの阻害薬としてのそれらの使用
JP5037336B2 (ja) 鎖長が延ばされ、置換されたシクロヘキシル−1,4−ジアミンの酸誘導体
JP2009520718A (ja) 鎮痛作用を有する置換されたオキサゾール誘導体
US6005118A (en) Methods of preparing 4-cyano-4 (substituted indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors
AU2002221632B8 (en) 5-amino-1-pentene-3-ol substituted derivatives
MX2008008067A (en) Substituted imidazoline derivatives
WO2002014272A1 (en) (thio)urea derivatives, process for their production and medicines containing the derivatives
AU723180B2 (en) Novel compound with platelet aggregation inhibitor activity
WO1995029910A1 (fr) Derive d'imidazolidinedione
HK1122019B (en) Substituted imidazoline derivatives
GB2413326A (en) Nefopam analogues

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090820

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20100518

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120717

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121016

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121023

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20121026

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121029

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121211

A045 Written measure of dismissal of application [lapsed due to lack of payment]

Free format text: JAPANESE INTERMEDIATE CODE: A045

Effective date: 20130514